John Zimmerman, MD
Clinical Cardiac Electrophysiology · Hackensack, NJNPI 1528036217
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,263 of the $11,645 with a category attached, or 62.4%. 28 manufacturers reported payments, led by Boston Scientific at 28.9% of the total. Reporting peaked in 2019 at $3,368 and has fallen 85.8% since, to $480 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in NJ, where the typical reported total is $15,131.
Across 261 payments — averaging $44.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Medtronic$3K
- Topera, Inc.$2K
- Medical Device Business Services, Inc.$981
- Biosense Webster, Inc.$372
- Biotronik Inc.$242
- plus $2K from 22 others
Across 19 payments — averaging $402.30 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$6K
- Biotronik Inc.$2K
What the payments were for
- Travel & lodging$2,14418%
- Food & beverage$7,26362%
- Education$120%
- Ownership interest$9929%
- Other$1,23411%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 84 | $3,361 |
| Medtronic(2 entities) | 64 | $2,854 |
| Topera, Inc. | 3 | $2,226 |
| Medical Device Business Services, Inc. | 4 | $981 |
| Biosense Webster, Inc. | 12 | $372 |
| Biotronik Inc. | 13 | $242 |
| Johnson & Johnson(2 entities) | 10 | $175 |
| Pfizer | 12 | $171 |
| Cvrx, Inc. | 1 | $163 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 8 | $157 |
| Abbott | 6 | $151 |
| Sanofi-aventis U.S. LLC | 10 | $135 |
| E.r. Squibb & Sons, L.L.C. | 7 | $102 |
| Boehringer Ingelheim | 4 | $60 |
| Impulse Dynamics (USA) Inc. | 2 | $59 |
| Atricure, Inc. | 3 | $55 |
| Irhythm Technologies, Inc. | 2 | $52 |
| Philips North America LLC | 3 | $51 |
| Baxter Healthcare | 1 | $50 |
| Actelion Pharmaceuticals US, Inc. | 2 | $40 |
| G Medical Diagnostic Services, Inc. | 2 | $31 |
| Lundbeck LLC | 2 | $29 |
| Edwards Lifesciences | 1 | $28 |
| Bayer | 1 | $26 |
| AstraZeneca | 1 | $24 |
| Cardiva Medical, Inc. | 1 | $23 |
| Novartis | 1 | $15 |
| Bardy Diagnostics, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,645 in reported general payments places this provider in the 40th percentile of 102 clinical cardiac electrophysiology providers in New Jersey.
See all clinical cardiac electrophysiology providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 35 | $38,361 |
| XareltoRivaroxaban | 15 | $20,243 |
| Flecainide Acetate | 38 | $1,523 |
| Amiodarone Hcl | 40 | $1,044 |
| Metoprolol Succinate | 39 | $649 |
| Metoprolol Tartrate | 12 | $44 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $171 | $38,36135 claims |
| Johnson & JohnsonXarelto | $175 | $20,24315 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 102 clinical cardiac electrophysiology providers in New Jersey.
Other clinical cardiac electrophysiology in Hackensack
- Gunjan ShuklaHackensack$83K
- Taya GlotzerHackensack$82K
- Sameer JamalHackensack$44K
- Glauco RadoslovichHackensack$15K
- Benjamin D SouzaCherry Hill$741K
- Suneet MittalParamus$722K
- George MarkHaddon Heights$312K
- Raffaele CorbisieroBrowns Mills$135K
- Emad AzizNewark$112K
- Marc RoelkeWest Orange$110K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.